← Open Payments lookup

DONALD HOLBROOKS: Open Payments

NPI 1346872512 · CLEMSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$686 in 42 payments from 12 companies in 2025. Trend: 2023 $1,042 · 2024 $638 · 2025 $686

Food & beverage: $686
CompanyPaymentsAmount
ABBVIE INC.22$286
Celgene Corporation4$82
Neurocrine BioSciences, Inc.4$79
Neurelis, Inc.3$58
TG Therapeutics, Inc.2$42
Alexion Pharmaceuticals, Inc.1$28
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$27
PFIZER INC.1$20
Otsuka America Pharmaceutical, Inc.1$19
Merck Sharp & Dohme LLC1$17

Products named: UBRELVY, ZEPOSIA, INGREZZA, VRAYLAR, VALTOCO, QULIPTA, BRIUMVI, ULTOMIRIS.

Industry payments across SC — which companies pay providers there.